Digital tools to help teens keep well when anxiety or depression are under control

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This fully digital trial studies whether a transdiagnostic app and a companion mastery course can help adolescents maintain well-being after periods of anxiety or depression. Participants use a research smartphone app to complete tasks and questionnaires, with some engaging in digital group sessions and others working independently. The study also explores the cost of providing these digital interventions. It is conducted at the University of Oslo with Scandinavian-language participants who are currently in remission or partially remitted from their previous symptoms.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Currently in full or partial remission for a minimum of 2 months from a depressive disorder or an anxiety disorder as defined by self-reported scores on RCADS-47: previous episode(s) of t-score \> 65 and current t-score =\<65.
* Native or fluent Scandinavian language skills.
* Willingness to take part even when allocated to the non-preferred arm of the trial.

Exclusion Criteria:

* Ongoing depressive disorder, ongoing anxiety disorder as defined by current t-score =\<65 on RCADS-47.
* Recent completion of one of the interventions in the two interventional arms.
* no available smartphone.

Where it's running

• University of Oslo
  Oslo, Norway Recruiting

Study contacts

• Study coordinator: Ragnhild Bø, Ph.D.
• Email: ragnhild.bo@psykologi.uio.no
• Phone: +47 41904595

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Group Unified Protocol for Emotional Disorders in adults in public mental health (UP in Spanish)

  A group-based Spanish version of the Unified Protocol is being tested with adults in public mental health to see if it helps anxiety, depression, and related symptoms.

  Recruiting University of La Rioja · Logroño, La Rioja · NCT07682064

• Near-infrared brain light for somatic symptoms in treatment-resistant depression

  This will test whether twice-weekly near‑infrared transcranial photobiomodulation at 10 Hz or 40 Hz can reduce depressive and physical (somatic) symptoms in people with treatment‑resistant depression who are already on antidepressants.

  Recruiting Taipei Veterans General Hospital, Taiwan · Taipei · NCT07543328

• Home transcranial direct current stimulation for major depression

  This study tests whether doing transcranial direct current stimulation (tDCS) at home—using either an accelerated or a conventional schedule—works as well and is as safe as receiving tDCS in a clinic for adults (18–65) with major depression who speak Spanish or Catalan.

  Recruiting at 2 sites Ionclinics & Deionic SL · L'Hospitalet de Llobregat, Barcelona and 2 other locations · NCT07510880

• Brain stimulation to improve attention in major depression

  This will test whether brief bursts of magnetic brain stimulation (iTBS) can improve selective attention in adults with major depressive disorder.

  Recruiting University of Electronic Science and Technology of China · Chengdu, Sichuan · NCT07111169

• Blood markers that predict TMS response in treatment-resistant depression

  This project will test whether blood protein and metabolic markers can predict how well transcranial magnetic stimulation (TMS) works for people with treatment-resistant depression.

  Recruiting at 2 sites Gulhane Training and Research Hospital · Ankara, Ankara and 1 other locations · NCT07039370

• Therapy for public speaking anxiety using mood treatments

  This study is testing whether adding a positive mood treatment or relaxation technique before exposure therapy can help people with social anxiety and public speaking fear feel less anxious.

  Recruiting at 2 sites University of California, Los Angeles · Los Angeles, California and 1 other locations · NCT06776991

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.